CARNEGIE ASSET MANAGEMENT
Carnegie Asset Management is a focused and independent asset manager. Their objective is to deliver consistent, long term asset growth for their clients. The combination of a unique investment philosophy based on careful stock-picking and long-term global trends coupled with a stable team of experienced portfolio managers, has over the past 20 years resulted in world-class investment results.
CARNEGIE ASSET MANAGEMENT
Social Links:
Status:
Closed
Contact:
+45 3546 3500
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Content Delivery Network Font Awesome Domain Not Resolving Microsoft Exchange Online Amazon
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2006-10-05 | Santhera Pharmaceuticals | Carnegie Asset Management investment in Series C - Santhera Pharmaceuticals | 15 M EUR |
| 2006-03-29 | Genizon BioSciences | Carnegie Asset Management investment in Venture Round - Genizon BioSciences | 12 M USD |
| 2005-12-20 | Santhera Pharmaceuticals | Carnegie Asset Management investment in Series B - Santhera Pharmaceuticals | 16 M EUR |
| 2004-12-13 | Genizon BioSciences | Carnegie Asset Management investment in Series B - Genizon BioSciences | 11.1 M CAD |
| 2002-03-04 | Agensys | Carnegie Asset Management investment in Series C - Agensys | 42.8 M USD |
| 2000-06-21 | ZoomON | Carnegie Asset Management investment in Series C - ZoomON | 8 M USD |